Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von ACCESSWIRE

ZeitAktuelle NachrichtenRatingLeser
MiCureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza ; Development in Collaboration with GSK625Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1) virus, considered to be potential future pandemic threatStudy will...
► Artikel lesen
MiAlta Global Group: Alta Academy Teams Up with UFC legend Daniel Cormier to Elevate Wrestling Training Worldwide305SYDNEY, AUSTRALIA / ACCESSWIRE / April 24, 2024 / Alta Global Group (NYSE American:MMA) ("Alta" or the "Company"), a leading name in martial arts and combat sports training, announced its latest collaboration...
► Artikel lesen
MiCoppernico Metals Inc.: Coppernico Receives Final Permits to Drill its Sombrero Copper-Gold Project in Southern Peru253VANCOUVER, BC / ACCESSWIRE / April 24, 2024 / Coppernico Metals Inc. ("Coppernico" or the "Company") is pleased to announce that its Peruvian subsidiary Sombrero Minerales S.A.C. has now received all...
► Artikel lesen
MiSenzime publishes annual and sustainability report for 202397UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ) announces today that the company's annual and sustainability report for 2023 is published and available...
► Artikel lesen
MiXcyte Digital Corp. to Present at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 202493POMPANO BEACH, FL / ACCESSWIRE / April 24, 2024 / Xcyte Digital Corp. (TSXV:XCYT) ("Xcyte" or the "Company"), a spatial computing event technology aggregator and developer providing a high value, cost-effective...
► Artikel lesen
MiTheralase Technologies Inc.: Theralase Closes $CAN 750,000 Non-Brokered Private Placement165TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage pharmaceutical company dedicated to the research...
► Artikel lesen
MiNutriband Inc.: Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch Through FDA Submission227Private Placement of $8.4 million has closed and will fund the commercial development of lead product AVERSA Fentanyl to NDA filingNutriband working to complete the commercial scale-up prior to performing...
► Artikel lesen
MiEcora Resources PLC Announces Transaction in Own Shares112Transaction in Own Shares LONDON, UK / ACCESSWIRE / April 24, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that on 23 April 2024, it purchased 250,000 ordinary shares of 2p each in the...
► Artikel lesen
MiAston Bay Holdings Ltd: Aston Bay Signs Definitive Agreement to Option the Epworth Sediment Hosted Copper-Silver-Zinc-Cobalt Project, Nunavut, Canada; Dr. Elizabeth Turner Joins Advisory Board317Expanding Aston Bay's large-scale high-grade copper portfolio TORONTO, ON / ACCESSWIRE / April 24, 2024 / Aston Bay Holdings Ltd. (TSX-V:BAY)(OTCQB:ATBHF) (the "Company" or "Aston Bay") is pleased to...
► Artikel lesen
MienVVeno Medical Corporation: Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium148Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement = 3 Points) including:9.29 Points for...
► Artikel lesen
MiTryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt163KELOWNA, BC / ACCESSWIRE / April 24, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF) is pleased to announce that the shareholders of Exopharm Limited ACN 163 765 991...
► Artikel lesen
MiEpique Realty Empowers Agents at PowerCON 2024 with More Free Benefits: Realty.com124Epique Realty sparks excitement once again by unveiling a unique and marvelous benefit for its agents with Realty.com HOUSTON, TX / ACCESSWIRE / April 24, 2024 / On the exhilarating second day of PowerCON...
► Artikel lesen
MiBenefits for Agents Keep on Coming at PowerCON as Epique Realty Introduces CliqueOffers123The momentum of excitement continues at PowerCON as Epique Realty unveils yet another valuable free benefit for agents: CliqueOffers HOUSTON, TX / ACCESSWIRE / April 24, 2024 / The momentum of excitement...
► Artikel lesen
MiBioz, Inc.: NeuroNexus is Leveraging Bioz's AI-Powered Citation Tools to Drive Increased Sales Conversion97PALO ALTO, CA / ACCESSWIRE / April 24, 2024 / Bioz, Inc., a Silicon Valley AI company, has partnered with NeuroNexus to provide a suite of digital citation widgets that display NeuroNexus' peer-reviewed...
► Artikel lesen
MiSenzime Wins Another Major US Veterans Affairs Contract; Expands Reach of TetraGraph System141UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in perioperative precision-based patient monitoring solutions, announced today that it has been...
► Artikel lesen
MiCESI Spa: CESI Solar Cells Fuels the Satellites of the Global Internet177MILAN, ITALY / ACCESSWIRE / April 24, 2024 / The Italian group CESI has secured a contract, with options valued at over one hundred million euros over five years, with one of the world's leading companies...
► Artikel lesen
MiBioInvent International AB: Interim Report January-March 2024108LUND, SWEDEN / ACCESSWIRE / April 24, 2024 / BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2...
► Artikel lesen
MiSpago Nanomedical Reports Favorable Data in Breast Cancer Model with Tumorad119LUND, SWEDEN / ACCESSWIRE / April 24, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today data from a non-clinical study exploring 177Lu-SN201 in a model for...
► Artikel lesen
MiEcora Resources PLC Announces Q1 2024 Trading Update260LONDON, UK / ACCESSWIRE / April 24, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) issues the following trading update for the period 1 January to 31 March 2024.Ecora is the leading royalty company...
► Artikel lesen
MiAngle PLC Announces New Commercial Agreement with AstraZeneca120ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE / April 24, 2024 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a...
► Artikel lesen
MiInterContinental Hotels Group PLC Announces Transaction in Own Shares - April 2478LONDON, UK / ACCESSWIRE / April 24, 2024 / The Company announces that on 23 April 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International...
► Artikel lesen
MiXVIVO Perfusion AB: Interim Report January-March 2024159GOTHENBURG, SWEDEN / ACCESSWIRE / April 24, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2024 (Jan 1 - Mar 31)• Net sales amounted to SEK 186.0 million (140.6), corresponding...
► Artikel lesen
MiEpique Realty Amazes Agents at PowerCON 2024 with Another Free Benefit: REDO by BASE136Epique unveils REDO by BASE, which is a progressive remodeling software service that empowers buyers to visualize their dream homes with incomparable precision. HOUSTON, TX / ACCESSWIRE / April 24,...
► Artikel lesen
MiKuros Biosciences AG: Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales297Financial HighlightsDirect MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1 2023; this corresponds to a sequential increase of 21.9% or CHF 2.5 million over Q4 2023Total...
► Artikel lesen
MiEvotec SE: Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth319FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCEPRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 MEVOTEC'S REPORTING...
► Artikel lesen